[
    "{\"step_by_step_thinking\": \"The question states that the pain management team recommends using a medication that can reduce the patient's opioid need through interaction with the NMDA-receptor. From the relevant documents, we can see that ketamine is an NMDA receptor antagonist that has been used for the management of refractory and neuropathic pain. Therefore, the most likely recommended agent in this case would be B. Ketamine.\", \"answer_choice\": \"B\"}"
]